Ototoxicity: therapeutic opportunities
- 1 October 2005
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 10 (19), 1313-1321
- https://doi.org/10.1016/s1359-6446(05)03552-x
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Flavanoid of Drynaria fortunei protects against gentamicin ototoxicityPhytotherapy Research, 2004
- WR-2721 (Amifostine) Ameliorates Cisplatin-Induced Hearing Loss But Causes Neurotoxicity In Hamsters: Dose-Dependent EffectsJournal of the Association for Research in Otolaryngology, 2004
- Protective effects of α-tocopherol and tiopronin against cisplatin-induced ototoxicityActa Oto-Laryngologica, 2004
- Vitamin E Reduces Cisplatin OtotoxicityThe Laryngoscope, 2004
- Round Window Application of D-Methionine, Sodium Thiosulfate, Brain-Derived Neurotrophic Factor, and Fibroblast Growth Factor-2 in Cisplatin-Induced OtotoxicityOtology & Neurotology, 2004
- Hearing and hair cells are protected by adenoviral gene therapy with TGF-β1 and GDNFMolecular Therapy, 2003
- Protective Effects of α-Tocopherol Against Gentamicin-induced Oto-vestibulo Toxicity: An Experimental StudyActa Oto-Laryngologica, 2003
- Cisplatin combined with tiopronin or sodium thiosulfateAnti-Cancer Drugs, 1999
- Efficacy and toxicity of very high-dose cisplatin in advanced ovarian carcinoma: 4-year survival analysis and neurological follow-upInternational Journal of Gynecologic Cancer, 1993
- Template Deoxyribonucleic Acid and the Control of ReplicationNature, 1965